ArticleFrontiers in molecular biosciences2026
Single-cell transcriptomic analysis identifies vascular smooth muscle cell transcriptional programs associated with human carotid plaque remodeling.
Article in Frontiers in molecular biosciences, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Vascular smooth muscle cells (VSMCs) contribute to plaque structure and exhibit diverse transcriptional programs in human atherosclerosis. Although human plaque single-cell studies have established substantial VSMC heterogeneity, an important unresolved question is whether discovery-defined programs remain recognizable across independent patients and sequencing platforms without forced integration, and whether those programs retain associations with plaque instability. We therefore focused on program-level reproducibility, inferred regulatory activity, continuous expression organization, and rupture-associated variation. Methods: We used three public human carotid plaque transcriptomic datasets in nonredundant analytical roles rather than merging all single-cell cohorts into a single atlas. GSE253903, a 10x Genomics single-cell cohort, was used for broad plaque mapping and focused VSMC characterization. SCENIC and transcriptional-continuum analyses were restricted to finalized VSMCs. Discovery signatures and assignment rules were frozen before independent assessment in the Smart-seq2 dataset GSE260657, with uncertain cells permitted to remain unassigned. GSE120521 supported exploratory paired comparison between relatively stable and visibly ruptured plaque regions. Results: Quality control retained 46,209 cells from 12 patients in GSE253903, including 3,784 primary VSMCs after removal of immune-like contaminants. Five descriptive VSMC programs were identified: canonical contractile, extracellular-matrix-associated/fibromyocyte-like, DLX-osteomodulated, stress-responsive, and interferon-associated. VSMC-restricted SCENIC analysis showed higher inferred Conclusion: Human carotid plaque VSMCs display heterogeneous transcriptional programs with program-associated inferred regulon activity and continuous expression organization. An uncertainty-aware, cross-platform assessment supported partial conservation of these programs and linked selected remodeling patterns to plaque instability. This framework is intended to complement, rather than replace, spatial and mechanistic studies by identifying reproducible program-level features that can be prioritized for localization and functional testing.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.